Fig. 4

Estimation of tumor-infiltrating immune cells and immune molecules using the risk assessment model. Tumor-Infiltrating Immune Cells (a XELL, b MCPCOUNTER, c QUANTISEQ, d CIBERSORT-ABS, e EPIC, f TIMER, g CIBERSORT) was significantly associated with the risk score, h patients in the high-risk group were more positively associated with tumor-infiltrating immune cells and immune molecules, whereas they were negatively associated with other tumor-infiltrating immune cells and immune molecules